Visualitza per autor "Aguilar-Company, Juan"
Ara mostrant els elements 1-3 d 3
-
Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries
Aguilar-Company, Juan; von Martial, Rascha; Gattringer, Thomas; Kobayashi, Adam; Fazekas, Franz; Istvan, Szikora; Feigin, Valery L.; Caso, Valeria; Fischer, Urs; Abilleira, Sònia; GALLOFRE, MIQUEL (SAGE Publishing, 2019-03) -
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
Gudiol, Carlota; Durà-Miralles, X.; Aguilar-Company, Juan; Hernández-Jiménez, P.; Martínez-Cutillas, M.; Fernández-Avilés, Francesc (Elsevier, 2021-09) -
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Bergas, Alba; Albasanz Puig, Adaia; Fernández-Cruz, Ana; Machado, Marina; Novo, Andrés; van Duin, David; Ruiz- Camps, Isabel; Aguilar-Company, Juan (American Society for Microbiology, 2022-06)